UnicoCell Biomed Co., Ltd.(TW:6794)
NT$64.80+0.30 (+0.47%)
TW:6794
UnicoCell Biomed Co., Ltd. Revenue
NT$64.80
At close:+0.30 (+0.47%)
UnicoCell Biomed Co., Ltd. (6794) Revenue
UnicoCell Biomed Co., Ltd. Revenue
UnicoCell Biomed Co., Ltd. had a revenue of 12.77M in the quarter ending Dec 31, 2025, with -26.38%. This bring the company's revenue in the last twelve months to 30.10M, Decreased 35.53%. In the fiscal year ending Dec 31, 2025, UnicoCell Biomed Co., Ltd. had annual revenue of 30.10M with -5.58% growth.
- Revenue (ttm)
- 30.10M
- Revenue Growth
- -48.98%
- P/S Ratio
- 136.35
- Revenue/Employee
- TWD 1,114,926
- Employees
- 27
- Market Cap
- TWD 4.10B
Revenue Chart
UnicoCell Biomed Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.10M | -1.78M | -5.58% |
| Dec 31, 2024 | 31.88M | 7.29M | 29.66% |
| Dec 31, 2023 | 24.59M | 10.19M | 70.79% |
| Dec 31, 2022 | 14.40M | 6.22M | 76.07% |
| Dec 31, 2021 | 8.18M | 4.20M | 105.35% |
| Dec 31, 2020 | 3.98M | -11.76M | -74.70% |
| Dec 31, 2019 | 15.74M | 10.24M | 186.54% |
| Dec 31, 2018 | 5.49M | -494.00K | -8.25% |
| Dec 31, 2017 | 5.99M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.